Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
アポトーシス調節因子
Document Type and Number:
Japanese Patent JP2004507225
Kind Code:
A
Abstract:
The invention provides human apoptosis regulators (APRG) and polynucleotides which identify and encode APRG. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of APRG.

Inventors:
Tongue, Wai Tom
Azimzai, Yarda
Yue, Henry
Burford, Neil
Ding, Lee
Elliott, Bick S
Arbiz, Chandra Es
Bogun, Mariah Earl
Application Number:
JP2002500719A
Publication Date:
March 11, 2004
Filing Date:
May 30, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Insight Genomics Incorporated
International Classes:
G01N33/50; A61K38/00; A61K45/00; A61K49/00; A61P1/04; A61P1/16; A61P1/18; A61P3/10; A61P5/14; A61P7/00; A61P7/06; A61P7/08; A61P9/10; A61P11/00; A61P11/06; A61P13/02; A61P13/08; A61P13/12; A61P15/00; A61P15/08; A61P15/10; A61P17/00; A61P17/06; A61P19/00; A61P19/04; A61P19/06; A61P21/00; A61P25/28; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P31/18; A61P33/00; A61P33/02; A61P35/00; A61P35/02; A61P37/02; A61P37/08; A61P43/00; C07K14/47; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/12; C12P21/02; C12P21/08; C12Q1/68; C12S3/14; G01N33/15; G01N33/53; G01N33/566; (IPC1-7): C12N15/09; A61K38/00; A61K45/00; A61K49/00; A61P1/04; A61P1/16; A61P1/18; A61P3/10; A61P5/14; A61P7/00; A61P7/06; A61P7/08; A61P9/10; A61P11/00; A61P11/06; A61P13/02; A61P13/08; A61P13/12; A61P15/00; A61P15/08; A61P15/10; A61P17/00; A61P17/06; A61P19/00; A61P19/04; A61P19/06; A61P21/00; A61P25/28; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P31/18; A61P33/00; A61P33/02; A61P35/00; A61P35/02; A61P37/02; A61P37/08; A61P43/00; C07K14/47; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; C12P21/08; C12Q1/68; C12S3/14; G01N33/15; G01N33/50; G01N33/53; G01N33/566
Attorney, Agent or Firm:
Yoichi Oshima